47 reports

  • 6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
  • GLOBAL - GASTROINTESTINAL CANCER LIQUID BIOPSY MARKET (MILLION US$), 2015 - 2017

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Biopsy
  • World
  • Forecast
  • Market Size
  • MDxHealth SA

REST OF WORLD PART D: ANNEXURE ##.

  • Biopsy
  • Europe
  • United States
  • World
  • Market Shares

Gastrointestinal Cancer ##. ##. ##.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

GLOBAL LIQUID BIOPSY MARKET FORECAST 2018-2026 ##.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostics
  • World
  • 6.3 LIQUID BIOPSY MARKET: COMPETITIVE TECHNOLOGY PORTFOLIO

(UK) COMPANY ## COMPANY ## Trovagene, Inc.

  • Biopsy
  • United States
  • Market Size
  • Biocept, Inc.
  • Biodesix Inc.
  • 8.5.2 Product Portfolio
  • 9. Global Biopsy Device Market - Mergers and Acquisitions/Key Deals

Intended for one-time use. ##.

  • Biopsy
  • World
  • Forecast
  • Boston Scientific Corporation
  • Hologic, Inc.

Gastrointestinal and Gliomas are the other important type of cancer.

  • Biopsy
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • North America

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • Europe

GASTROINTESTINAL (GI) BIOPSY ##. ##. ##.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • APAC

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Australasia
  • Australia
  • Oceania
  • Forecast
  • 9. Global Biopsy Device Market - Mergers and Acquisitions/Key Deals

These instruments are intended for endoscopic gastrointestinal biopsy and should not be used for any purpose other than their intended function.

  • Biopsy
  • Breast Cancer
  • World
  • Boston Scientific Corporation
  • Hologic, Inc.

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Southern Europe
  • Spain
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Brazil
  • South America
  • Forecast
  • Medtronic, Inc.

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Latin America
  • Mexico
  • North America
  • Forecast

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • China
  • East Asia
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • India
  • South Asia
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Italy
  • Southern Europe
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • East Asia
  • South Korea
  • Forecast
  • Olympus Corporation

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • Eastern Europe
  • Russia
  • Forecast
  • Medtronic, Inc.

ENTERAL STENTS ARE PRIMARILY USED TO MAINTAIN PATENCY OF THE LUMEN OF THE GASTROINTESTINAL TRACT.

  • Biopsy
  • East Asia
  • Japan
  • Forecast
  • Olympus Corporation

The market by type of procedure is also discussed, which includes trends and market estimates of key therapeutic areas such as breast cancer, gastrointestinal cancer, lung cancer and cervical cancer, among others.

  • Biopsy
  • Diagnostic Imaging
  • Diagnostics
  • World
  • SELECTED CTDNA-BASED LIQUID BIOPSY TESTS IN DEVELOPMENT, 2017
  • GENOMIC HEALTH

THE PAN-CANCER PANEL TEST WILL DETECT MORE THAN ## SNV, INSERTIONS AND DELETIONS ON SEVEN ONCOGENES SPECIFIC TO LUNG, PANCREATIC, COLORECTAL, MELANOMA, AND GASTROINTESTINAL STROMAL TUMORS.

  • Biopsy
  • World
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group

The auto exports exceeded over ## million each year.

  • Diagnostic Reagent
  • China
  • Demand
  • Market Size
  • Biosino Bio-Technology & Science Inc

Excisional Biopsy ##.

  • Biopsy
  • United States
  • B. Braun Melsungen AG
  • Becton Property Group
  • Boston Scientific Corporation

Jia No. ##, Hualan Ave., Xinxiang, Henan, ## P. R.

  • Diagnostic Reagent
  • China
  • Beijing BGI-GBI Biotech Co., Ltd
  • Biosino Bio-Technology & Science Inc
  • Livzon Group

Jia No. ##, Hualan Ave., Xinxiang, Henan, ## P. R.

  • Diagnostic Reagent
  • China
  • Beijing BGI-GBI Biotech Co., Ltd
  • Biosino Bio-Technology & Science Inc
  • Livzon Group
  • 2.4 THE SITUATION TODAY - BIOPSY ANALYSIS
  • 4.46 CIRCULOGENE LIQUID BIOPSY DETECTS NEW TUMOR MASS EARLIER THAN CURRENT IMAGING METHODS

The double-balloon " push-pull" technique allows visualization and biopsy of the entire gastrointestinal tract.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • 2.4 THE SITUATION TODAY - BIOPSY ANALYSIS
  • 4.46 CIRCULOGENE LIQUID BIOPSY DETECTS NEW TUMOR MASS EARLIER THAN CURRENT IMAGING METHODS

The double-balloon " push-pull" technique allows visualization and biopsy of the entire gastrointestinal tract.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.